Oscar Health, Inc.
OSCR
$31.76
-$1.25-3.79%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 70.58% | 52.58% | 17.12% | 23.10% | 29.06% |
| Total Other Revenue | -6.19% | 32.06% | 86.31% | 79.65% | 24.20% |
| Total Revenue | 70.40% | 52.55% | 17.25% | 23.21% | 29.04% |
| Cost of Revenue | 48.63% | 42.94% | 26.87% | 29.06% | 49.41% |
| Gross Profit | 249.16% | 80.18% | -43.43% | -4.73% | -39.10% |
| SG&A Expenses | 29.30% | 46.29% | 9.71% | 13.30% | 22.81% |
| Depreciation & Amortization | -13.06% | 4.28% | -14.65% | -2.51% | -8.30% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.15% | 43.43% | 23.57% | 26.03% | 43.82% |
| Operating Income | 268.62% | 136.97% | -125.92% | -167.19% | -439.89% |
| Income Before Tax | 264.01% | 142.45% | -129.48% | -166.27% | -483.17% |
| Income Tax Expenses | 519.88% | 55.45% | 38.86% | -187.04% | -208.80% |
| Earnings from Continuing Operations | 258.36% | 146.46% | -129.92% | -152.78% | -505.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -115.38% | 88.51% | 32.44% | 116.35% | 223.81% |
| Net Income | 258.44% | 146.66% | -129.64% | -151.76% | -506.29% |
| EBIT | 268.62% | 136.97% | -125.92% | -167.19% | -439.89% |
| EBITDA | 276.57% | 134.03% | -135.29% | -198.33% | -396.39% |
| EPS Basic | 233.96% | 107.86% | -101.24% | -136.02% | -479.49% |
| Normalized Basic EPS | 238.78% | 104.58% | -100.72% | -148.04% | -458.48% |
| EPS Diluted | 222.67% | 125.61% | -82.65% | -136.02% | -537.87% |
| Normalized Diluted EPS | 225.79% | 125.24% | -100.72% | -148.04% | -556.56% |
| Average Basic Shares Outstanding | 18.27% | 18.67% | 14.12% | 6.65% | 7.06% |
| Average Diluted Shares Outstanding | 30.49% | 7.78% | 14.12% | 6.65% | -15.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |